Table 1.

Sequence of primers including EMT-related molecules, RSK4, and β-actin

Molecule	Primer
RSK4 forward	AATACTACCATTCGCTCCTCA
RSK4 reverse	TTACAGGCCAGTTGATGTTCGC
H-actin forward	GTCCACCGCAAATGCTTCTA
H-actin reverse	TGCTGTCACCTTCACCGTTC
H-CLDN-2 forward	GGCTTTCCACAGAGAGACGGG
H-CLDN-2 reverse	CAAGCAGCCTCAAGAAGGCAT
H-E-cadherin forward	CTTTGACGCCGAGAGCTAC
H-E-cadherin reverse	TTTGAATCGGGTGTCGAGGG
H-P53 forward	CCTCCTCAGCATCTTATCCG
H-P53 reverse	TTCCGTCCCAGTAGATTACCA
H-Snail forward	AGGACACATTAGAACTCACACGG
H-Snail reverse	CGAGTAAACATTGATTGCGTCAC
H-TGF-β forward	TACCTGAACCCGTGTTGCTCT
H-TGF-β reverse	TTTCCCCTCCACGGCTCAAC
H-twist forward	TGGCCTGCAAAACCATAGTCA
H-twist reverse	AGACACCGGATCTATTTGCAT
H-Vimentin forward	TCAGAATATGAAGGAGGAAATGGC
H-Vimentin reverse	GAGTGGGTATCAACCAGAGGGAGT

EMT epithelial–mesenchymal transition, RSK4 P90 Ribosomal Protein S6 kinase 4, TGF-β transforming growth factor beta